ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,880Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 676

$1.19M Total Retail Price of All Prescriptions

Rank: 32 out of 676

816 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 816 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

36% of this provider’s 816 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 22,307 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 1,944 1,351 S3 1 1
ZOLPIDEM TARTRATE 818 601 2 21
AMLODIPINE BESYLATE 773 696 3 3
LEVOTHYROXINE SODIUM 762 615 4 7
GLIMEPIRIDE 695 521 5 30
MELOXICAM 685 567 6 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 654 480 7 16
OMEPRAZOLE 645 475 8 2
FUROSEMIDE 609 463 9 4
SIMVASTATIN 586 529 10 6
PANTOPRAZOLE SODIUM 533 392 11 42
GABAPENTIN 483 315 12 10
METOPROLOL SUCCINATE 470 338 13 14
METFORMIN HCL 448 349 14 8
CARISOPRODOL 431 233 R 15 60
TRAMADOL HCL 400 303 16 19
LISINOPRIL 383 327 17 5
POTASSIUM CHLORIDE 330 272 18 9
CITALOPRAM HBR 298 233 19 17
DOXYCYCLINE HYCLATE 273 188 20 82
CEPHALEXIN 270 212 21 84
DIOVAN 266 215 22 37
METOPROLOL TARTRATE 259 198 23 22
NEXIUM 254 160 24 23
CLOPIDOGREL 254 228 24 28
CIPROFLOXACIN HCL 233 190 26 45
DICLOFENAC POTASSIUM 227 186 27 199
CYCLOBENZAPRINE HCL 225 119 R 28 50
LEVOFLOXACIN 213 165 29 91
ATORVASTATIN CALCIUM 211 164 30 20
WARFARIN SODIUM 199 158 31 18
AMITRIPTYLINE HCL 198 149 R 32 46
ATENOLOL 192 130 33 25
DIOVAN HCT 191 154 34 41
LEVOCETIRIZINE DIHYDROCHLORIDE 184 148 35 213
TRICOR 184 143 35 126
CLOTRIMAZOLE-BETAMETHASONE 179 139 37 170
METOLAZONE 173 120 38 172
AMLODIPINE BESYLATE-BENAZEPRIL 173 138 38 44
PLAVIX 169 153 40 40
TAMSULOSIN HCL 164 135 41 38
MUPIROCIN 161 118 42 146
HYDROCHLOROTHIAZIDE 160 145 43 12
TORSEMIDE 158 142 44 159
POLYETHYLENE GLYCOL 3350 156 136 45 56
FLUTICASONE PROPIONATE 155 91 46 49
METHYLPREDNISOLONE 154 123 47 124
CRESTOR 152 116 48 29
NAPROXEN SODIUM 150 133 49 194
SYNTHROID 150 126 49 48
RAMIPRIL 150 118 49 86
DIGOXIN 150 132 49 52
CILOSTAZOL 149 120 53 123
ESTRADIOL 147 117 R 54 109
PREDNISONE 141 131 55 53
COMBIVENT 137 90 56 174
ISOSORBIDE MONONITRATE ER 134 105 57 54
LYRICA 133 98 58 57
BYSTOLIC 132 125 59 96
FENOFIBRATE 132 106 59 90
CARVEDILOL 131 110 61 15
SERTRALINE HCL 130 70 62 26
TIZANIDINE HCL 128 93 63 68
ROPINIROLE HCL 127 85 64 85
TRAZODONE HCL 126 112 65 36
PRAVASTATIN SODIUM 126 123 65 11
ALLOPURINOL 126 90 65 31
CYMBALTA 114 77 68 47
AGGRENOX 114 108 68 147
MECLIZINE HCL 111 99 70 83
TRIAMTERENE-HCTZ 110 97 71 43
ESCITALOPRAM OXALATE 109 102 72 73
GLIPIZIDE 104 95 73 81
KLOR-CON M20 102 69 74 67
NAMENDA 98 98 75 35
LANTUS 98 57 75 55
VERAPAMIL ER 98 89 75 101
PROMETHAZINE HCL 94 45 R 78 75
LOSARTAN-HYDROCHLOROTHIAZIDE 90 61 79 51
PAROXETINE HCL 88 57 80 65
LOVASTATIN 85 57 81 33
FAMOTIDINE 81 70 82 64
PRAMIPEXOLE DIHYDROCHLORIDE 81 59 82 204
SPIRONOLACTONE 80 72 84 62
BENAZEPRIL HCL 79 79 85 58
BISOPROLOL-HYDROCHLOROTHIAZIDE 79 51 85 140
SUCRALFATE 77 66 87 187
CEFDINIR 76 69 88 185
CARBIDOPA-LEVODOPA 76 63 88 114
SPIRIVA 76 71 88 97
DEXILANT 75 46 91 155
BUMETANIDE 73 57 92 196
PREMARIN 73 72 R 92 128
DONEPEZIL HCL 72 72 94 24
LOSARTAN POTASSIUM 72 67 94 34
ZETIA 72 60 94 89
CELEBREX 71 50 97 108
CLARITHROMYCIN 70 47 98 256
ENALAPRIL MALEATE 69 15 99 65
LEVOXYL 68 61 100 186
ADVAIR DISKUS 67 51 101 87
LEXAPRO 66 64 102 210
ALENDRONATE SODIUM 66 66 102 61
METOCLOPRAMIDE HCL 63 53 104 107
JANUVIA 62 51 105 78
SINGULAIR 62 51 105 80
RANITIDINE HCL 61 51 107 27
SOTALOL 61 61 107 221
DILTIAZEM ER 60 45 109 118
HUMULIN N 59 43 110 264
NIFEDIPINE ER 59 38 110 100
CLONIDINE HCL 58 56 112 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 41 113 74
TAZTIA XT 55 38 114 287
AMIODARONE HCL 55 55 114 154
NAPROXEN 54 46 116 71
OXYBUTYNIN CHLORIDE 54 37 116 149
TOPIRAMATE 53 22 118 141
VALACYCLOVIR 53 26 118 292
TERBINAFINE HCL 52 49 120 426
ABILIFY 51 51 121 133
BENICAR HCT 50 26 122 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.